Guchelaar, H.J.

patient study cancer polymorphism melanoma treatment response association effect sunitinib pharmacogenetic statin analysis table number factor estrogen incidence netherland pharmacokinetic result survival genotype grade diagnosis therapy exposure population alternative drug control group nsaid haplotype pharmo toxicity hypertension women tumor 3 years receptor cutaneous melanoma breslow thickness enzyme inhibitor disease signi smoking allele breslow research interaction phase analyses signi ficantly imatinib clopidogrel prescription danusertib cutaneou alternative kinase blood trial multivariate cm diagnosis statin use outcome article heart oncol level palga sunitinib treatment platelet thickness regression warfarin arthritis cyp 2c cycle